In brachytherapy, the core of precision radiotherapy, treatment needles serve as the sole physical channel delivering radioactive sources to tumor target areas. This slender metal tube is tasked with penetrating normal tissues under image guidance, achieving precise positioning, and ensuring radioactive sources stably dwell or release radiation at predetermined locations. The reliability of its performance directly affects accurate delivery of radiotherapy doses, protection of surrounding healthy tissues, and patient treatment safety. The primary factor defining its performance limits and safety baseline lies in its fundamental constituent materials. Leading brachytherapy needle manufacturers make prudent selections and conduct sophisticated processing of medical‑grade stainless steel and titanium alloys. Far beyond simple cost‑benefit trade‑offs, this represents profound integration based on radiation physics, biocompatibility, mechanical engineering and long‑term implantation safety, aiming to construct a robust, reliable and bio‑friendly delivery system for every high‑dose irradiation session.

Medical‑grade stainless steel, particularly 316L or higher‑grade austenitic stainless steel, is the most widely used and classic material for brachytherapy needles. Manufacturers' long‑standing preference for it stems from its outstanding balance among strength, machinability, cost‑effectiveness and moderate biocompatibility. For interstitial needles requiring repeated puncture positioning or temporary indwelling during treatment (such as those used in high‑dose‑rate after‑loading therapy), the high rigidity and superior wear resistance of stainless steel are critical. It must withstand resistance from soft tissues and potential bony structures during puncture, maintain the preset needle insertion trajectory, and avoid bending or deviation - essential for realizing precise dose distribution planned by the Treatment Planning System (TPS). Its favorable corrosion resistance resists erosion from tissue fluids and common disinfectants, ensuring stable performance during single‑session or limited‑use treatments. In addition, mature stainless steel machining processes enable production of cannulas with smooth inner walls and minimal dimensional tolerances via precision drawing, grinding and polishing. This is vital for the smooth movement, precise positioning and retraction of radioactive sources (e.g., Iridium‑192 source wires) inside cannulas, directly determining the accuracy of dose delivery.

However, when treatment scenarios involve permanent implantation, such as Iodine‑125 seed implantation for prostate cancer, long‑term material biocompatibility and imaging compatibility become decisive factors. In such cases, titanium alloy stands as the undisputed material of choice. The most prominent advantages of titanium alloy are its unparalleled biological inertness and favorable compatibility with human tissues. The dense titanium‑oxide passive film spontaneously formed on its surface features extremely stable chemical properties, effectively blocking metal‑ion release and virtually eliminating inflammation, allergies or tissue rejection reactions that may arise after long‑term implantation. This serves as an absolute safety prerequisite for radioactive seed casings intended for permanent indwelling in the human body. As verified by research results, seed casings for encapsulating Iodine‑125 are manufactured from titanium tubes. Their wall thickness is precisely calculated to guarantee sufficient mechanical strength without causing excessive radiation attenuation.

Beyond biocompatibility, another major advantage of titanium alloy for permanent implantation applications is its non‑ferromagnetic property. Following treatment, patients may require MRI examinations to evaluate therapeutic efficacy or monitor other conditions. Titanium alloy implants generate no displacement or heat in strong magnetic fields and cause minimal imaging artifacts, ensuring the feasibility and clarity of subsequent imaging follow‑ups. Although raw‑material and processing costs for titanium alloy exceed those of stainless steel, it acts as a key material for building core product competitiveness in permanent implantation applications that pursue ultimate long‑term safety and avoid any potential biological interference.

Manufacturers' material expertise is further reflected in in‑depth exploitation of material properties combined with process optimization. Whether stainless steel or titanium alloy, raw‑material purity and consistency are the primary screening criteria. Medical‑grade materials impose strict limits on impurity elements such as carbon, sulfur and phosphorus. Subsequent precision machining, such as multi‑axis CNC grinding, ensures needle tips feature optimal bevel angles and cutting‑edge sharpness to minimize puncture resistance and tissue trauma. Surface finishing processes including electrolytic polishing eliminate micro‑burrs and render both inner and outer cannula walls mirror‑smooth. This not only reduces tissue friction during puncture but also ensures unobstructed movement paths for radioactive sources, preventing source wire jams caused by rough tube walls - the lifeline of treatment safety and dose accuracy.

Therefore, manufacturers' deep engagement in materials science for brachytherapy needles essentially translates cutting‑edge material‑science properties into quantifiable precision and safety in clinical radiotherapy. Through profound understanding and differentiated application of stainless steel and titanium alloy, they provide radiation oncologists and medical physicists with highly reliable tools adaptable to different treatment modes (temporary interstitial implantation vs. permanent implantation) and diverse clinical needs. This fine needle carries not only the physical function of delivering radiation but also manufacturers' commitment to exact radiation‑dose delivery and high responsibility for patients' long‑term health. In the era of precision radiotherapy, materials serve as the physical cornerstone enabling safe implementation of all high‑dose, high‑precision treatments.